Objective-To perform genetic sex typing during the Barcelona Olympic Games using polymerase chain reaction (PCR) amplification of Y chromosome specific sequences.
All the operations were carried out by female officials in areas specially allocated where men were not allowed. Buccal smears samples from both sides of the mouth (samples a and b) of each competitor were taken with a sterile filtered tip and deposited on 100 ml of sterile water. Tubes were labelled and introduced into a box, on the top of which another label with the same number was attached. The fourth identical label was attached to the identification key sheet that was picked up twice a day by a messenger from the organising committee of the Barcelona Olympic Games (COOB). The box containing the samples was sent to the laboratory at 2 and 8 pm. The general scheme of the test is shown in fig 1. Sample a was boiled for 10 minutes, spun down in a microfuge, and PCR amplification of a sequence specific for the DYZ 1 repeated element was performed as indicated below from 10 ml of total extract. An internal control was always included in our experiments, using two oligos, M1-M2, specific for mitochondrial DNA.9 Samples that showed amplification of the DYZ1 fragment (positive result) or those that did not show amplification either of DYZ 1 or Mito fragment (not determined result) were subjected to further analyses (see fig 2) . In this case, DNA was purified from the two samples obtained from the same individual using a DNA purification kit commercialised by Linus (Madrid, Spain). These two samples were used as templates in two parallel reactions of amplification, one with D l-D2 (for DYZ1) and M1-M2 (for mitochondrial fragment) primers and another with S 1-S2 (for SRY) primers (see fig 3) . Only those samples that showed amplification of both D1-D2 and S1-S2 were reported as "positives" to the COOB. These positive results were communicated personally, in order to maintain confidentiality of the results of the assay. The whole process took four to five hours and never lasted longer than 36 hours.
Gender verification in sporting events Reactions of amplification were performed in 20 ml using standard conditions (10 mM Tris-HC1, pH 8.3; 50 mM KCl; 1.5 mM MgCl2; 200 mM of each dNTP) with 50 ng of each primer (D1-D2 and M1-M2) or 150 ng (S1-S2), and 0.8 units of AmpliTaq DNA polymerase (Perkin Elmer). Ten microlitres of a total lysate of the buccal smear (from 100 ml total) were used as template. Samples were subjected to 43 cycles (950C -15 s, 500C -15 s, 720C -20 s) with a final polymerisation step of three minutes at 720C, in a GeneAmp PCR System 9600 thermocycler from Perkin Elmer Instruments. The presence of the amplified sequence was checked by electrophoresis in gels of polyacrylamide (6%) in TBE buffer (89 mM Tris-borate, pH 8.3; 2 mM EDTA) and staining in ethidium bromide (0.5 mg ml-' for 10 minutes).
Results and discussion
We describe here the assay used in Barcelona Olympic Games for genetic sex determination. This assay was performed in two steps: in the first screening, the presence of the DYZ 1 repeat was analysed in total lysates of buccal smears taken from the female competitors, using primers D1-D2. As an internal control, coamplification of a sequence specific for mitochondrial DNA was performed using primers M1-M2. The quickness of this assay allowed us to obtain results within four hours after the arrival of the sample, since no DNA purification was required. In our previous studies, amplification of DYZ1 specific sequences was detected in 100% of the control male samples (89/89), and in none of 1629 female samples. However, when the female competitors from the Barcelona Olympic Games were analysed with this assay, 11 samples rendered a positive result (11/2406; 0.46%). In a second screening, SRY and DYZ1 specific sequences were amplified from purified DNA from these 11 samples, using primers 51-S2 and D1-D2. Five of these 11 samples showed the presence of the SRY specific sequence. According to the criteria of the IOC Medical Commission that only SRY and DYZ1 positive athletes were considered for further analysis, only these five competitors were subjected to a physical examination. In the remaining six cases, amplification of DYZI was detected but not that of SRY; a representative case is shown in fig 4 (sample  Y 2) . Identical results were obtained in duplicate samples from the same subjects.
The Y-PCR assay used to determine genetic sex in Barcelona Olympic Games was performed in two steps. A first screening deter- mined the presence of DYZ1 by PCR amplification from total cell lysates. However, the positive cases had to be double checked for SRY presence because some samples that were DYZ1 positive did not yield SRY amplification products. The reasons for this discrepancy are still unknown since reasons of ethics did not allow us to perform a more extensive analysis of these samples, which were destroyed after the competition. Two plausible explanations are as follows. (1) Due to the high number of DYZ1 repeats in the male genome, it is likely that samples are more prone to be contaminated for DYZ 1 that for SRY gene. However, it should be pointed out that very strict conditions were taken to prevent contaminations (for instance, only female officials were involved in the sampling and processing) and contaminations were never detected in our previous extensive analyses. (2) It is also possible that these samples correspond to athletes who had suffered a partial translocation of Y chromosome. Unfortunately, the athletes were not identified and further studies could not be performed, but it would have been interesting to have been able to prove this hypothesis. If this second possibility were correct, our analysis would also suggest a more widespread presence of DYZ 1 in athletes than in the general female population, although the number of cases analysed was not enough statistically to conclude that there was a higher prevalence. However, it is also possible that the differences in the presence of DYZ1 might arise from other alternative explanations, as the ethnic diversity of the competitors.
Due to the high copy number of the DYZ1 repeat in the Y chromosome, amplification of sequences specific for this element has been used to study genetic sex in samples containing very few cells by FISH and NISH techniques.'0"1 Our results suggest that the use of DYZ 1 as marker of genetic sex might lead to errors in the classification of the samples, at least in sports competitors, and recommend the use of SRY sequences for genetic sex typing.
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